China Digest: Biotech firm BoomRay bags $43m in Series B; E-commerce enabler Pook raises almost $29m

Chinese biotech firm BoomRay Pharmaceuticals has raised 300 million yuan ($43.4 million) in a Series B round led by Sequoia China. Meanwhile, brand enablement platform Pook has bagged 200 million yuan ($28.8 million) in a Series B round led by Hong Kong-based Jebsen Capital.